Markedsdata leveret af TwelveData og Morningstar
Leo International Precision Health AG is a healthcare holding company focused on building an integrated, AI-driven precision health ecosystem. Its business spans four complementary areas: healthcare services, MedTech, HealthTech, and biotech. The company manages a portfolio of businesses providing personalized care, pain rehabilitation, clinical laboratory testing, digital health solutions, medical diagnostics, biotechnology products, and wellness offerings. These activities include AI-assisted drug discovery and repurposing, digital pathology, liquid biopsy analysis, predictive healthcare software, personalized prevention and treatment services, and specialized clinical care. Its portfolio companies operate across international healthcare and life sciences markets, with particular exposure to Asia, Europe, North America, and Australia. Leo International Precision Health AG connects data, technology, medical expertise, and operational capabilities across its holdings, supporting collaboration between clinical services, diagnostics, software, and research-oriented businesses. Through this structure, the company serves as a platform for healthcare innovation across the precision medicine value chain, from disease detection and prevention to treatment, rehabilitation, and ongoing wellness management.